Philippa R Kennedy

11PUBLICATIONS
92CO-AUTHORS
Micro- and nanosystemsPredictive and prognostic markersQuery processing and optimisationMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 13, 2026
Reprogramming endogenous NK circuits by highly efficient nonviral genome editing.

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.

|Apr 03, 2026
NetTracer3D Enables User-Friendly Analysis of Diverse Microscopic and Medical 3D Datasets.

Liam Mclaughlin, Mia Curic, Siddhartha Sharma

|Oct 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Jul 24, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.

Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy

|Nov 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.

Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier

Pageof 2

Frequent Collaborators

6 joint publications

Martin Felices

4 joint publications

Nicholas A Zorko

4 joint publications

Jeffrey S Miller

3 joint publications

Quinlan M Kile